医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

First-Ever World Kidney Cancer Q&A Day Highlights Growing Global Burden

2017年06月19日 PM10:00
このエントリーをはてなブックマークに追加


 

AMSTERDAM

Kidney cancer is a silent disease that’s on the rise. The global incidence of kidney cancer is predicted to increase by a shocking 22 percent by 2020. Explanations are incomplete, but include risk factors such as ageing, obesity, high blood pressure and smoking.

The lack of answers is why the International Kidney Cancer Coalition (IKCC) and kidney cancer organisations worldwide are marking the first-ever World Kidney Cancer Q&A Day. On June 22, patients, carers, health care professionals and local organisations will be asking questions and seeking answers:

  • What explains the varying incidence of kidney cancer worldwide? High incidence rates are seen in northern and eastern Europe, North America and Australia, with the highest rates estimated in the Czech Republic?
  • How can we address the growing gap in mortality rates for kidney cancer between emerging and developed economies?
  • How can we prevent kidney cancer, or detect it earlier when patients can still be cured?

“We need global collaboration for kidney cancer – in research, awareness and advocacy – because when we work together we have a greater impact than we do alone and can drive significant change for patients,” says Dr. Rachel Giles, Chair, IKCC.

A new paper authored by leading experts, The Global Burden of Kidney Cancer: A Call to Action (under review) underscores the challenges faced in diagnosis and disease management.

The IKCC also launched the World Kidney Cancer Day Q&A Quiz. Available in nine languages, the seven-question quiz tests what you know – and what you need to know – about kidney cancer. For every quiz completed, $5 will be directed to a high-priority research project that will benefit patients worldwide.

Great Voice, Great Cause
Globally-recognized celebrity and humanitarian Juliet Ibrahim is the campaign’s Global Ambassador.

“Just like art, kidney cancer knows no boundaries. Working together – sharing our experience and our knowledge – we make a difference for the people affected by kidney cancer,” says Juliet. The Juliet Ibrahim Foundation gives hope to kidney cancer patients throughout Africa.

World Kidney Cancer Q&A Day has been established by the IKCC (www.ikcc.org), a global body of 30 cancer organisations focused on improving the lives of people affected by kidney cancer. The campaign is supported by Bristol-Myers Squibb, Novartis, Pfizer, and Ipsen.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170619005250/en/

CONTACT

Reverb Consulting Group
Jilda Lazer, 1-647-290-7573
jilda.lazer@reverbconsulting.ca

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Samsung Bioepis Announces Results of Additional One-Year Follow-Up Study Comparing Event-Free Survival of SB3 Trastuzumab Biosimilar Candidate to Reference Trastuzumab by ADCC Activity
  • Aptorum Group Limited Announces Pricing of Initial Public Offering
  • Seattle Genetics和武田呈报 ADCETRIS® (Brentuximab Vedotin)用于表达CD30的外周T细胞淋巴瘤一线治疗3期ECHELON-2临床试验的阳性数据
  • 武田の株主がシャイアー買収案に関連した決議事項を承認
  • 武田股东批准拟收购Shire plc相关决议